Treatment by I131 therapy in hemodialysis: About a case

Journal of Nephrology & Therapeutics

ISSN: 2161-0959

Open Access

Treatment by I131 therapy in hemodialysis: About a case

10th European Nephrology Conference

October 24-26, 2016 Rome, Italy

Baya Guerd, Dahnoun, M Chiad, Y Boulahia and D Iftene

Central Hospital of Army, Algeria

Posters & Accepted Abstracts: J Nephrol Ther

Abstract :

The incidence of the thyroid cancer to chronic kidney disease (CKD) was estimated to be 02% twice as frequent in the women; the coverage does not differ from that of the patient with normal renal function. The prescription of an I131 therapy as therapeutic complement is possible in theory, and despite a low risk of external radiation; we dispose of very few data and no recommendation exists for this category of patients. We report the case of a 29-year-old female patient with end stage renal disease (ESRD) dialyzed 3 times in week, in whom a thyroid papillary carcinoma was discovered during an assessment for transplantation or a treatment by I131 therapy was indicate advenged then of two cures.

Biography :

B Guerd is a Medical Doctor graduated from the University of Algiers in November, 2005. She worked on emergencies from August, 2006 till October, 2007. She began her Specialty in November, 2007 and is Specialist in Nephrology from the University of Algiers (April, 2013). She is also Senior Assistant at the Medical Department, University of Algiers (April, 2015). She is working as Nephrologist at the Central Hospital of the Army, Algiers from April, 2013 till now.


Google Scholar citation report
Citations: 784

Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report

Journal of Nephrology & Therapeutics peer review process verified at publons

Indexed In

arrow_upward arrow_upward